Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Emgality in Post-Traumatic Migrainous Headaches
NCT06901518Phase 4Completed
- Sponsor
- Albany Medical College
- Start
- Aug 2020
- Primary completion
- Jun 2024
- Modality
- Recombinant Proteins and Enzymes, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 4 trial of galcanezumab in post-traumatic headache (PTH), sponsored by Albany Medical College. Started Aug 2020; status: completed.
02
Drugs
galcanezumab
03
Conditions
post-traumatic headache (PTH)
Beyond the preview
Go deeper on NCT06901518.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06901518.